首页> 外文期刊>Journal of plastic, reconstructive & aesthetic surgery: JPRAS >A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren's contracture of the hand
【24h】

A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren's contracture of the hand

机译:胶原酶注射与外科筋膜切除术治疗手足挛缩症的单中心成本比较分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background and aim The options for treating patients with Dupuytren's contracture have broadened with the introduction of collagenase. Although the literature would suggest that collagenase treatment is effective, has few complications and is popular with patients, it has not been widely commissioned by the National Health Services of the United Kingdom and other European countries due to concerns about cost. The aim of this study was to compare the cost of surgical fasciectomy to collagenase injections for the treatment of Dupuytren's contracture in a single centre. Method Prospective data on 40 patients undergoing fasciectomy or collagenase injection (20 patients in each group) were collected between January and March 2013. Financial data on the costs of the procedures, equipment, theatre time and follow-up appointments were calculated. Results The average cost of an open partial fasciectomy pathway was £7115.34 and that of a collagenase pathway was £2110.62. Eight collagenase patients had physician-led follow-up appointments and only three had hand physiotherapy appointments. By contrast, every fasciectomy patient had at least one physician and one physiotherapist follow-up appointment routinely. Conclusion The results of this study demonstrate that collagenase treatment for Dupuytren's contracture of a single digit in selected patients is just over £5000 less than treatment for the same condition using surgical fasciectomy. Collagenase-treated patients require much less physician- and physiotherapist-led postoperative follow-up.
机译:背景和目的随着胶原酶的引入,治疗Dupuytren挛缩症的患者的选择范围已经扩大。尽管文献表明胶原酶治疗有效,并发症少并且在患者中很受欢迎,但由于对成本的担忧,并未得到英国国家卫生服务局和其他欧洲国家的广泛委托。这项研究的目的是在一个中心比较外科筋膜切除术与胶原酶注射治疗杜普伊特氏挛缩的费用。方法收集2013年1月至2013年3月间40例接受筋膜切除术或胶原酶注射治疗的患者(每组20例)的前瞻性数据。计算有关手术费用,设备,手术时间和随访的财务数据。结果开放式部分筋膜切除术途径的平均费用为£ 7115.34,胶原酶途径的平均费用为£ 2110.62。 8名胶原酶患者进行了医师指导的随访,只有3名进行了手部物理治疗。相比之下,每位筋膜切除术患者至少要定期安排一名医师和一名物理治疗师的随访。结论这项研究的结果表明,在某些患者中,用胶原酶治疗Dupuytren的单个手指挛缩症比采用相同的条件进行手术的筋膜切除术治疗少了5,000英镑。胶原酶治疗的患者需要更少的医师和物理治疗师指导的术后随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号